 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2001, 21(21):8387-8395
Plasma Membrane Ganglioside Sialidase Regulates Axonal Growth and
Regeneration in Hippocampal Neurons in Culture
Jose Abad
Rodriguez2, 3,
Eugenia
Piddini3,
Takafumi
Hasegawa1,
Taeko
Miyagi1, and
Carlos G.
Dotti2, 3
1 Miyagi Prefectural Cancer Center, Division of
Biochemistry, Medeshima-Shiode, Natori, Miyagi, 981-1293 Japan,
2 Cavalieri Ottolenghi Scientific Institute, Universita
degli Studi di Torino, A. O. San Luigi Gonzaga, Regione Gonzole
10, 10043 Orbassano (TO), Italy, and 3 Cell Biology and
Biophysics Program, European Molecular Biology Laboratory, 69012 Heidelberg, Germany
 |
ABSTRACT |
It has been long recognized that the ganglioside GM1 plays a role
in axonal growth and neuronal differentiation. However, the involvement
of plasma membrane GM1 has been difficult to elucidate. This is
possible now thanks to the recent cloning of plasma membrane ganglioside sialidase (PMGS), the enzyme responsible for the localized hydrolysis of oligosialogangliosides into GM1. In this work we show
that PMGS mRNA and protein levels are high at early developmental stages of the hippocampus and low in adulthood both in
vivo and in vitro. We also demonstrate that
inhibition of PMGS activity blocks axonal elongation, whereas the
increase in PMGS activity dramatically enhances axon growth
and accelerates the polarization of cytoskeletal proteins. Finally, we
show that axotomy close to the cell body in PMGS overexpressing neurons
results in the regrowth of the original axon instead of randomly, as is
the case in control neurons. In all, these results imply that PMGS
activity through the modulation of GM1 surface levels is an important
component of the machinery controlling axonal growth. We hypothesize
that increasing PMGS activity in the adult nervous system may be useful to improve regeneration after nerve damage.
Key words:
plasma membrane sialidase; ganglioside; hippocampal
neuron; axonal growth; axonal regeneration
 |
INTRODUCTION |
Axonal growth in vivo is
a complex event in which the mechanisms of elongation and guidance must
coordinately interplay. Despite the many years of intense work, only
recently has a general picture emerged of how elongation and guidance
are regulated at the molecular level (for review, see Tessier-Lavigne
and Goodman, 1996 ; Suter and Forscher, 1998 ; Quinn et al., 1999 ;
Andersen and Bi, 2000 ; Bradke and Dotti, 2000 ). Regarding the early
event of axon formation, much of our current knowledge comes from
studies in neuronal cells growing in culture. Thus, we know that axonal
elongation requires the addition of new membrane at the tip of the
growing neurite, an increase in the dynamics of actin fibers at the
same site, an increase in the stability of the trailing microtubules in
the shaft, and constant changes in the binding properties of membrane proteins and membrane lipids to the extracellular matrix. In this last
event, gangliosides seem to play a major role.
Gangliosides are sialic acid-containing glycosphingolipids particularly
enriched in the nervous tissue. Like most gangliosides, the
monosialoganglioside GM1 was shown to modulate the growth and
differentiation of neuroblastoma cells (Masco et al., 1991 ; Wu and
Ledeen, 1991 ). In cultured neurons, ganglioside biosynthesis is
essential for axonogenesis, axonal growth (Harel and Futerman, 1993 ;
Schwarz et al., 1995 ), and synaptogenesis (Inokuchi et al., 1997 ).
Also, addition of exogenous GM1 promotes differentiation and neurite
outgrowth of neuronal cells in cultures (Facci et al., 1984 ; Skaper et
al., 1985 ; Leeden, 1989 ), and the possible potentiation of effect of
some neurotrophic factors has been suggested (Katoh-Semba et
al., 1984 ). More recently, the influence of gangliosides on the action
of neurotrophins has been documented. In particular, GM1 interacts with
the NGF receptors TrkA (Mutoh et al., 1993 , 1995 ; Ferrari et al., 1995 ;
Rabin and Mocchetti, 1995 ) and p75NGFR
(Panni et al., 1998 ), as well as with the BDNF receptor TrkB (Pitto et
al., 1998 ). The use of GM1 binding reagents, like the subunit B of
cholera toxin (Chtx-B), and anti-GM1 antibodies also supports a role
for GM1 in axonal growth. Thus, Chtx-B was shown to induce
differentiation in N18 neuroblastoma cells (Masco et al., 1991 ) and to
block neuraminidase-induced neuritogenesis. Similarly, antibodies to
GM1 have been shown to inhibit the NGF-induced sprouting of
chick embryonic dorsal root ganglion cells (Schwartz and Spirman, 1982 )
and conditioned media-stimulated growth in sensory ganglion cells
(Spoerri et al., 1988 ). Additionally, Wu and Ledeen, (1994)
demonstrated that anti-GM1 antibodies inhibit the differentiation of
Neuro2a cells stimulated by different agents. All of this evidence is
clearly indicative of GM1 playing a role in axonal growth, but most of
the experimentation has depended on the addition of
exogenous GM1 or GM1 blockers to cultures of neuron-like cell lines.
These facts prompted us to investigate the physiological role of the
endogenous plasma membrane GM1 in primary neurons. For that purpose we
have modified the levels and activity of plasma membrane ganglioside
sialidase (PMGS) in hippocampal neurons in primary culture. PMGS is
unique in specifically hydrolyzing oligosialogangliosides to produce
GM1 in plasma membrane (Miyagi et al., 1999 ; Wada et al., 1999 ;
Hasegawa et al., 2000 ).
 |
MATERIALS AND METHODS |
Isolation of mRNA and RT-PCR.
Poly(A+) RNA was affinity purified with
the QuickPrep Micro mRNA purification kit (Amersham Pharmacia Biotech,
Uppsala, Sweden) from isolated hippocampi [both from embryonic day (E)
15 embryos and from 2-month-old adult mice].
cDNA synthesis was performed using ~10 ng of mRNA and the Moloney
murine leukemia virus reverse transcriptase (Advantage RT-for-PCR kit,
Clontech Laboratories, Palo Alto, CA). Specific primers were designed
to monitor membrane sialidase expression by PCR amplification (forward:
TCAATTGGCAAAGGTGCTCCCGCTACTCAG; reverse:
GGGCTGGTACAGTCTTCACAGCTCAGGACC). The PCR reactions contained ~1 ng
cDNA, 1 µl of a 10 mM solution of each dNTP, 1 U
AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, CT), 20 pmol of each
primer, in 1× Perkin-Elmer PCR Buffer (containing 1.5 mM
MgCl2) in a total volume of 50 µl. The PCR
amplification consisted of 33 cycles of (1) 10 sec denaturation step at
94°C, (2) 10 sec annealing at 62°C, and (3) 30 sec extension at
72°C. A Perkin-Elmer model gene Amp PCR system 2400 was used. To
obtain a semiquantitative analysis, primers specific for the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) housekeeping gene
(forward: GACCACAGTCCATGACATCACT; reverse: TCCACCACCCTGTTGCTGTAG; 20 pmol each) were added to the PCR reactions; the GAPDH cDNA was used as
internal standard to normalize the concentration of the different cDNA
samples. Because the GAPDH mRNA was more abundant than the sialidase
mRNA, the sialidase cDNA was allowed to undergo six initial cycles of
amplification before addition of GAPDH primers. Under those PCR
conditions, none of the cDNAs was amplified to saturation.
A densitometric analysis of the band intensities was performed using
the NIH Image software.
Cell culture. Primary hippocampal neurons derived from rat
embryos were cultured following the protocol of Goslin and Banker (1991) and de Hoop et al. (1997) . In brief, the hippocampi of E18 rats
were dissected, trypsinized, and physically dissociated. The cells were
then washed in HBSS, and 100,000 cells (25,000 for neurite length
measurements) were plated onto poly-L-lysine (PLL) or laminin-treated glass coverslips in 6 cm Petri dishes containing minimal essential medium (MEM) and 10% heat-inactivated horse serum. The cells were kept in 5% CO2 at
36.5°C. After 7 hr the coverslips were transferred to a 6 cm dish
containing astrocytes in MEM and N2 supplements containing 0.5 mM
2,3,dehydro-2,deoxy-N-acetylneuraminic acid (NeuAc2en) in
the case of PMGS inhibitor-treated cultures, or 10 µg/ml cholera
toxin-subunit B in GM1 binding-blocking experiments.
For biochemical purposes cells were plated onto 3 cm tissue culture
dishes containing MEM-N2 medium and incubated the same way as before.
COS cells were plated in 3 cm Petri dishes (10,000 cells per
dish) containing DMEM supplemented with 10% heat-inactivated fetal
calf serum (FCS).
Axon transection. One-day-old neurons either transfected or
nontransfected with the PMGS cDNA (see below) were plated on
PLL-treated Cellocate coverslips (Eppendorf, Hamburg, Germany). The
coverslips were then transferred into a tissue culture dish filled with
medium equilibrated to air concentration of gases onto a microscope
stage equipped with a micromanipulator (Eppendorf). Cells were
localized on the coverslip grid using a 32× long-distance working
lens. The longest neurite was then cut by pulling, orthogonally across the neurite, a microinjection glass needle over the glass surface. The
distance between the cell body and the cut site was similar to the
second longest neurite. Cells were photographed before and shortly
after lesioning. The coverslip was then placed in the original medium
and returned to the incubator. After 24 hr, cells were fixed and
labeled with anti-hemagglutinin (HA) antibody (see below).
Lesioned cells were then relocalized and newly photographed.
Immunocytochemistry. For the detection of tubulin-, MAP-2-,
tau-, and HA-tagged PMGS, cultured neurons were fixed in 4%
paraformaldehyde for 15 min at room temperature, aldehyde groups were
quenched in 50 mM ammonium chloride for 5 min,
and the cells were then extracted with 0.1% Triton X-100 for 3 min.
The neurons were blocked in blocking solution for 1 hr at room
temperature and then incubated with rabbit anti-HA (Santa Cruz
Biotechnology, Santa Cruz, CA), polyclonal antibody 514 anti-MAP2 (a
gift from C. Sanchez, Centro de Biologia Molecular, Madrid), mAb
anti-tau (Tau-1, Roche Diagnostics, Mannheim, Germany), and mAb
anti-tubulin (Amersham Pharmacia Biotech). Incubations were performed
for 1 hr at room temperature. After extensive washing with PBS, cells
were incubated with species-specific secondary antibodies.
Western blotting. Samples of plasma membranes of neuronal or
COS cells were dissolved in Laemmli's sample buffer (5×) and loaded
onto 12% polyacrylamide PAGE-SDS gels (30 µg of protein per line).
The proteins were transferred to nitrocellulose filters and blocked for
2 hr with 5% defatted milk, 0.1% Tween 20 in PBS (PBST) at room
temperature. The filters were then incubated overnight at 4°C with
polyclonal antibodies raised against PMGS or with polyclonal anti-HA
antibodies (Santa Cruz Biotechnology). After they were washed
thoroughly with PBST, the filters were incubated with horseradish
peroxidase-labeled anti-rabbit antibodies for 1 hr at room temperature,
washed, and developed by the ECL system (Amersham Pharmacia Biotech).
Neurite length measurements. Control or NeuAc2en-treated
(0.5 mM) neuron cultures were labeled with mAb
anti-tubulin as described before, and 20 random fields per experiment
were photographed using a Zeiss Axiovert 135 microscope equipped with
an acrostigmat 20× objective.
The neurite length (80-100 cells per experiment) was measured from the
cell body to the growth cone using NIH Image 1.58 software. For axon
transection experiments, the axonal regrowth was measured from the cut
site to the new growth cone. In the case of growth of a different
neurite, the measurement was from the tip of the growing neurite before
the lesion to the growth cone 24 hr after. The grid of the Cellocate
coverslips was used as reference.
Expression of HA-tagged murine plasma membrane ganglioside
sialidase in COS-1 cells and hippocampal neurons. A sialidase
expression plasmid coding for the murine PMGS with an HA-tag at the C
terminus was constructed as follows. Two primers, (1)
5'-AAGCTTGCCACCATGGAGGAAGTCCCACCC, introducing a HindIII
site and a Kozac (Kozac, 1989 ) sequence, and (2)
5'-GCGGCCGCCCGTCGCTACTAGGG-CTG, introducing a NotI site, were used to amplify the sequence encoding the entire open reading frame from template cDNA synthesized from mouse brain
poly(A+) RNA (Hasegawa et al., 2000 ). PCR
products were cloned into a pCRII-TOPO vector (Invitrogen, San Diego,
CA) following manufacturer's instructions. The sialidase was then
subcloned into PMH expression vector (Roche Diagnostics, Mannheim,
Germany) using HindIII and NotI restriction
sites. The construct was verified by sequencing.
To verify the activity of the sialidase encoded by this construct,
3 × 106 COS-1 cells per milliliter
were transfected by electroporation with the empty expression vector or
with the construct (20 µg of DNA/300 µl of cell suspension) using a
Bio-Rad (Bio-Rad, Hercules, CA) Genepulser operated at 250 V and 500 µF. After 3 d in culture as described above, the cells were
washed with PBS, scraped, pelleted, lysed by ultrasonication in 9 vol
of cold PBS, and centrifuged at 1000 × g for 10 min at
4°C. The supernatant was further centrifuged at 100,000 × g for 1 hr at 4°C. The pellet was used in the sialidase assay as the membrane fraction. Rat hippocampal neurons were
transfected in the same way as COS cells, but the capacitance was set
to 250 µF.
Sialidase assay: ganglioside analysis and sialic acid
quantification. The assay mixture contained 50 nmol of
ganglioside-bound sialic acid (bovine mixed gangliosides; Matreya
Inc.), 0.2 mg of BSA, 15 µmol of sodium acetate, pH 4.6, 0.2 mg of
Triton X-100, and membrane samples in 0.2 ml (plasma membranes from
3 × 106 COS cells or 5 × 106 primary neurons). After 1 hr
incubation at 37°C, the reaction was taken up to 2 ml with water and
loaded on a C18 reversed-phase column (Merck, Darmstadt, Germany) as
described by Reuter and Schauer (1994) . Released sialic acid was
recovered in the nonretained fraction, whereas gangliosides were
recovered by elution with methanol. Aqueous nonretained fraction was
lyophilized and methanol fraction was vacuum dried.
Eluted gangliosides were resuspended by sonication in 30 µl of
methanol and chromatographed on a high-performance thin-layer chromatographic plate (Merck, Darmstadt, Germany) in
chloroform/methanol/0.2% CaCl2 (55:45:10 v/v/v).
Ganglioside bands were visualized with resorcinol-HCl reagent as
described by Schnaar and Needham (1994) . Released sialic acid was
measured by the method of Warren (1959) , as modified by Chaplin (1986) ,
using N-acetylneuraminic acid as standard.
 |
RESULTS |
PMGS mRNA, protein, and activity are high at early
developmental stages
Taking into account that addition of GM1 to cultured neuronal
cells facilitates axonal growth (see introductory remarks), we
predicted that the levels and activity of the enzyme responsible for
its plasma membrane synthesis should be higher at developmental stages
when axonal growth is the maximum. To test this hypothesis we measured
PMGS mRNA, protein, and activity in hippocampal neurons in
situ and in vitro. Template cDNA from embryonic (E15)
and adult (2-month-old) mouse hippocampi was PCR amplified with PMGS
gene-specific primers (see Materials and Methods). The abundance of
GAPDH mRNA in the two samples was used as internal standard to
normalize the concentration of the cDNA samples. The expression level
of PMGS mRNA was significantly higher at earlier developmental stages (Fig. 1A). The
bar graph in Figure 1A shows the
quantification of the relative abundance of PMGS mRNA in embryonic
versus adult hippocampi in four independent experiments. Although a
certain variability in the values from different experiments was
observed, PMGS transcripts were reproducibly more enriched at the
embryonic hippocampal stage (10.5× on average) (Fig.
1A, black bar). The result of one
representative experiment is shown in the bottom panel of
Figure 1A.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 1.
PMGS is highly expressed during early stages of
neuronal differentiation. A, Quantification of the
relative enrichment of PMGS mRNA in four independent RT-PCR
experiments. Semiquantitative RT-PCR analysis shows that PMGS is
significantly more expressed in embryonic than in adult hippocampi.
Each gray bar represents the ratio of PMGS mRNA
concentration in embryonic hippocampi (E15) over that
found in adult hippocampi (postnatal day 60) for a given experiment, as
measured by densitometric analysis of the band intensities. The mean is
indicated by the black bar. Error bar corresponds to the
SD. The bottom panel shows the result of a
representative experiment. The expression level of the housekeeping
gene GAPDH was used to normalize the mRNA concentration.
B, Western blot using polyclonal anti-PMGS antibody of
membrane extracts from hippocampal neurons grown on PLL or on
laminin-coated dishes. Neurons grown on laminin express much higher
levels of PMGS than those grown on PLL. In this case the higher
expression occurs after 3 d in culture. A second band (labeled
a) of ~5 kDa higher molecular weight could represent a
post-translational modification. The two lanes labeled
preimm. show the reprobing with preimmune serum of the
blot for laminin-grown cells. This demonstrates that the bottom band
(labeled b) is nonspecific. In the right
lane (HA), we localized the PMGS band by probing
membranes from HA-PMGS-overexpressing neurons with anti-HA antibody.
C, Quantification of PMGS activity in membranes from
PLL- and laminin-grown cells. Sialic acid release from a mixture of
oligosialogangliosides of such confirmed the high activity of the
enzyme in laminin-grown neurons.
|
|
The levels of PMGS protein were investigated in embryonic hippocampal
neurons grown in culture conditions, a well suited experimental system
for neuronal differentiation studies (for review, see Craig and Banker,
1994 ; Bradke and Dotti, 2000 ). Western blotting of the membrane
fraction of neurons grown for 1 and 3 d in either laminin or PLL
was performed using a polyclonal anti-PMGS antibody (Fig.
1B). PMGS levels in laminin-grown cells were higher
than from cells grown in PLL. Moreover, the levels were significantly higher in cells grown for 3 d on PLL than for those grown for 1 d. The difference between neurons seeded on laminin or PLL can be explained by the fact that laminin is a naturally occurring extracellular matrix protein present in the hippocampus and that these
cells grow axons much faster than the axons of the same neurons grown
on PLL (Manthorpe et al., 1983 ; Lein et al., 1992 ; Esch et al.,
1999 ).
The hydrolyzing capacity of PMGS at different developmental stages was
also tested in membranes of hippocampal neurons grown for different
times and on different substrata. Quantitative analysis of the sialic
acid hydrolyzed by membranes of neurons cultured on PLL or laminin is
shown in Figure 1C. The membranes from neurons grown on
laminin for 1 and 3 d showed between 2.5- and 3-fold higher
activity than in the case of cells grown for 3 d on PLL (Fig. 1
C, PMGS activity). Enzymatic levels were
undetectable in neurons grown for 1 d on PLL. Considering that by
day 1 hippocampal neurons grown on PLL are just sprouting neurites, and
only by day 3 are a large number of them actively elongating axons
(Dotti et al., 1988 ), the patterns of expression just described show the existence of a temporal correlation between PMGS high levels and
neuritogenesis. Whether the activity of the enzyme plays a direct role
in neuritogenesis was tested next in gain and loss of function experiments.
Inhibition of neuronal PMGS activity diminishes neurite growth
PMGS hydrolyzes sialic acid from plasma membrane
oligosialogangliosides, releasing 2-3- and 2-8-bound sialic
acids to thus produce plasma membrane GM1 (Saito et al., 1995 ; Kopitz
et al., 1996 ; Hata et al., 1998 , Miyagi et al., 1999 ). To inhibit the activity of PMGS, cultured hippocampal neurons grown on laminin or PLL
were treated with the specific inhibitor NeuAc2en. Studies in different
cell types have already shown that the activity of the enzyme is
blocked with this inhibitor (Kopitz et al., 1996 , 1997 ). NeuAc2en was
added to the laminin-seeded neurons shortly after attachment (6 hr
in vitro), and the effect on axonal and dendritic length and
number was measured 18 hr later. Untreated laminin-grown neurons showed
long axons (Fig. 2C,
arrowheads). Addition of NeuAc2en to sister neurons
drastically affected this phenotype, and most neurons presented only
short neurites (Fig. 2D, arrowheads).
Quantification of the effect of NeuAc2en was performed measuring
neuritic length of treated and control cultures and splitting the
measurements into three categories: short neurites (10-20 µm),
neurites of intermediate length (20-40 µm), and clearly identifiable
axons (>40 µm). NeuAc2en treatment reduced the number of axons from
31% (untreated) to 7%, whereas the number of short neurites was
enhanced from 41% (control) to 72% (Fig. 2E,
three bar sets on the right). Although to a
lesser extent, a similar inhibitory effect was observed on PLL-cultured
neurons (Fig. 2A,B,E, three bar sets on the left). This latter effect
was not surprising because axonal growth is much slower on PLL than on
laminin (Manthorpe et al., 1983 ). Similar results were obtained
blocking GM1 with the subunit B of cholera toxin (see Fig.
5A,B).

View larger version (75K):
[in this window]
[in a new window]
|
Figure 2.
Inhibition of PMGS activity retards axonal growth.
A-D, Morphological appearance of
hippocampal neurons grown on PLL (A, B)
or on laminin (C, D) in the presence
(B, D) or absence (A,
C) of 0.5 mM NeuAc2en. The inhibitor was
added 6 hr after plating the cells and incubated for 18 hr. All the
cells were stained with monoclonal anti-tubulin antibody to visualize
the processes. Note the poor differentiation of cells treated with the
inhibitor. E, Quantification of neuritic length of the
experiment shown above. Neuritic length was measured as indicated in
Materials and Methods. The results were divided in three
categories: 10- to 20-µm-long neurites, 20- to 40-µm-long neurites,
and neurites >40 µm. Black bars and gray
bars represent the percentage of neurites in each
category for control and treated cultures, respectively. The results
correspond to the average of three experiments. Error bars correspond
to the SD.
|
|
To confirm that the observed effect of NeuAc2en was caused by a true
reduction of surface GM1, we treated hippocampal neurons in culture and
analyzed ChTx-B binding by immunofluorescence. A treatment
identical to that performed for the functional analysis (see above)
resulted in an 8× loss of FITC-cholera toxin-subunit B binding (data
not shown).
Increase of PMGS enzymatic activity accelerates axonal growth
Because inhibition of PMGS activity blocks GM1 synthesis and
axonal elongation (Fig. 2), we hypothesized that an increase in PMGS
activity would produce neurons with longer neurites. Before testing
this hypothesis in neurons, we controlled in COS-1 cells, which are
more manageable for biochemical analysis, if PMGS overexpression resulted in a true, higher enzymatic activity. Cell were transfected with the PMGS plasmid, and the distribution and activity of the newly
made protein were analyzed by immunofluorescence microscopy, Western
blotting, and thin-layer chromatography. Two days after transfection,
overexpressing cells showed intracellular and membrane labeling with
the anti-HA antibody (Fig.
3A). The presence of the
protein in the membrane fraction was also demonstrated by Western
blotting (Fig. 3A). Enzymatic activity was analyzed using a
mix of oligosialogangliosides as substratum (see Materials and Methods). The plasma membranes of transfected cells released 69.3 µmol of sialic acid per hour per milligram of protein (Fig.
3C, PMGS). The enzymatic activity of plasma
membranes from vector-alone transfected cells was undetectable (Fig.
3C, vector). In agreement with this
quantification, the thin-layer chromatography in Figure 3B
shows qualitatively how the membranes from transfected cells (PMGS) efficiently hydrolyzed the oligosialogangliosides in
the original mixture producing GM1. Contrarily, the membranes from cells transfected with the expression vector alone or from
nontransfected cells did not show such activity (Fig. 3B,
vector and control, respectively).

View larger version (56K):
[in this window]
[in a new window]
|
Figure 3.
Overexpressed HA-PMGS is properly localized and
fully functional. A, COS-1 cells were transfected with
HA-PMGS cDNA (see Materials and Methods for details) and grown for 48 hr. The immunofluorescence with anti-HA antibodies shows a strong
expression of HA-PMGS on the plasma membrane (A,
left panel). A Western blot with the same
antibody confirmed a high level of expression for plasma membranes from
transfected cells (inset, PMGS
overexp. lane), whereas for membranes
from control cells the expression is undetectable
(inset, Control lane).
B, C, Plasma membranes from
PMGS-transfected or vector-transfected COS-1 cells were incubated with
a mixture of standard gangliosides in the presence of Triton X-100. The
resulting gangliosides and the released sialic acid were separated by
reversed-phase chromatography. Gangliosides were qualitatively analyzed
by thin-layer chromatography with resorcinol staining
(B), and sialic acid was quantitated using a
thyobarbituric acid assay (C). Membranes from
PMGS-transfected cells hydrolyzed all the polysialilated
gangliosides forming GM1 and releasing 69.3 nmol of sialic acid per
hour per milligram of protein (PMGS lane). In the case
of membranes from vector-transfected cells (vector
lane), as in a control without membranes (control
lane), polysialilated gangliosides remained undigested, and
released sialic acid could not be detected (n.d.,
nondetectable).
|
|
Once we demonstrated that the enzyme encoded by our HA-PMGS construct
was properly located and fully functional, we tested the effect of PMGS
overexpression in the differentiation of hippocampal neurons in
culture. Neurons grown on either laminin or PLL were transfected with
the above construct, and neuritic number and length were measured 24 hr
later. In the control situation (empty expression vector) using PLL as
substratum, most neurons were in stage 1 (round, no processes) or stage
2 (several short neurites), and very few were in the polarized stage 3 (one long and several short neurites) (Dotti et al., 1988 ). Quite
dramatically, under the same condition of culture, PMGS overexpression
in neurons (Fig.
4A-D,
arrows) from a parallel culture resulted in the appearance of numerous neurons with one or two very long axon-like neurites (>40
µm) (Fig. 4A-D, arrowheads).
Quantitation of neuritic number and length revealed that overexpression
increased the number of processes >40 µm from 7% (untransfected) to
37%. Consistently, the number of neurites of intermediate length was
strongly decreased (26% for overexpressing cells and 52% for
controls) (Fig. 4E, central bar set). This
effect could be reverted by blocking GM1 with cholera toxin-subunit B
(Fig. 5C). Together with the
previous data on PMGS inhibition, these last results strongly suggest
the involvement of PMGS in axonal growth.

View larger version (71K):
[in this window]
[in a new window]
|
Figure 4.
PMGS overexpression accelerates axonal growth in
cultured hippocampal neurons. A-D,
Hippocampal neurons were transfected with HA-PMGS cDNA and plated on
PLL-coated coverslips. After 24 hr the cells were fixed and
immunolabeled with anti-HA antibodies. To better illustrate the effect
of overexpression, pairs of neurons overexpressing HA-PMGS
(arrows) and nontransfected (asterisks)
neurons are shown. The overexpressing neurons showed long and branched
axons (A, B, arrowheads),
whereas non-overexpressing cells (A, B,
asterisks) presented only short neurites.
E, Quantitation of neurite length for control
(gray bars) and PMGS-overexpressing neurons
(black bars) after 24 hr in culture. PMGS-overexpressing
neurons showed 38% of axons >40 µm, whereas this group represents
only 7% for control cells. The intermediate group of neurites, on the
contrary, was significantly reduced from 51% in controls to 26% in
transfected cells. The quantification was made on a total of 100 overexpressing cells and 100 control cells from three independent
experiments. We considered a cell as "overexpressing" when the
anti-HA fluorescence intensity of the cell body was >2.5 times the
background level measured on nontransfected cultures. Error bars
correspond to the SD.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Figure 5.
Inhibition of surface GM1 binding with cholera
toxin-subunit B retards early axonal growth and reverts the effect of
PMGS overexpression. Control (A, B,
black bars) or PMGS-overexpressing hippocampal neurons
(C, black bars) grown on PLL were treated
with 10 µg/ml cholera toxin-subunit B
(A-C, gray bars). The
reagent was added 6 hr after plating and maintained for 18 or 42 hr.
After incubation the cells were fixed at 24 (A,
C) or 48 hr (B) in
paraformaldehyde and photographed. Neuritic length was measured as
indicated in Materials and Methods. The results from two
independent experiments were divided into three categories: 10- to
20-µm-long neurites, 20- to 40-µm-long neurites, and neurites >40
µm. Error bars correspond to the SD.
|
|
Overexpression of PMGS promotes early axonal and dendritic
cytoskeleton segregation
To determine whether PMGS-mediated acceleration in growth rate
also accelerates overall neuronal maturation, we analyzed the distribution of the microtubule-associated proteins tau and MAP2 in control and PMGS-overexpressing neurons. These proteins become segregated to axons and dendrites, respectively, not earlier than 4-5
d in culture (Caceres et al., 1984 , 1986 ). Figure
6A shows a control
neuron grown in culture for 72 hr, immunostained for tau and MAP2.
Consistent with previous work at this time in culture, both proteins
were uniformly distributed to the axon and dendrites. Conversely, PMGS-
overexpressing neurons presented a clear axonal polarization of tau
(Fig. 6B, arrowheads) and dendritic
polarization of MAP2 (Fig. 6C, arrowheads) as
early as 36 hr after plating. These results suggest that the
acceleration of axonal growth driven by the increased expression of
PMGS and GM1 speed up neuronal maturation, at least regarding
polarization of cytoskeletal proteins.

View larger version (60K):
[in this window]
[in a new window]
|
Figure 6.
PMGS overexpression produces an early polarization
of the axonal marker tau and the dendritic marker MAP2.
A, Hippocampal neurons were plated on PLL-coated
coverslips, fixed after 72 hr in culture, and double immunostained for
tau and MAP2. At this moment the expression of both markers appeared
evenly distributed along the whole cell. B,
C, Hippocampal neurons transfected with HA-PMGS cDNA
were fixed after 36 hr in culture and double immunostained for tau and
HA (B) or HA and MAP2 (C).
In these cells tau was clearly polarized to the axon (B,
arrowheads), and MAP2 was clearly polarized to the
somatodendritic domain (C,
arrowheads).
|
|
PMGS overexpression increases the regeneration capacity of the
initial axon
Given that PMGS overexpression enhanced axonal growth and
maturation, it became essential to investigate whether the response to
axotomy was modified as well. To address this question we cut the axons
of stage 3 PMGS-overexpressing hippocampal neurons and analyzed their
capacity to regenerate. Axons were sectioned in such a way that the
proximal stump was left with a length similar to or shorter than that
of the other neurites (Fig.
7A,B,
white lines). The rationale behind such procedures was to
return the neuron to a stage in which all processes would have similar
chances to become the new axon (Goslin and Banker, 1991 ). Consistent
with that concept, lesioned control neurons regrew a new axon from a
neurite different from that sectioned (Fig. 7A, black
arrowhead, white arrowheads). On the contrary, a
similar experiment in PMGS-overexpressing cells resulted in the growth
of a new axon from the sectioned axonal stump (Fig. 7B,
white and black arrowheads). Seventy percent of
control lesioned neurons grew a different axon after axotomy. Contrarily, in 71% of PMGS-overexpressing neurons, the sectioned axon
regrew as such (Fig. 7C). To demonstrate further the
specificity of this effect, PMGS-overexpressing cells were incubated in
the presence of the PMGS inhibitor NeuAc2en and then axotomized. Under these conditions 60% of PMGS-overexpressing neurons grew a different axon (Fig. 7C, right bar set).

View larger version (67K):
[in this window]
[in a new window]
|
Figure 7.
PMGS-overexpressing neurons
regenerate an axon from the same process originally sectioned, even
after proximal axotomy. A, Hippocampal neurons were
plated on PLL-coated Cellocate coverslips and grown for 24 hr. At that
time the axons were sectioned at a distance from the cell body similar
to the length of the longest dendrite (A, before
axotomy, white lines). Twenty-four hours after
the sectioning the cells were fixed and relocalized using
the Cellocate grid as reference. The sectioned axons appeared stacked
at the point where they were cut (A, 24 hours
later, and black arrowhead), and one of the
dendrites grew as the new axon (A, 24 hours
later, and white arrowheads). B,
The axons of HA-PMGS-transfected neurons were sectioned
and allowed to recover as for cells in A; then the cells
were fixed and immunolabeled with anti-HA antibodies. Twenty-four hours
after axotomy, the same axons grew again from the point of the cut
(B, 24 hours later,
arrowheads), and the dendrites remained unaltered.
C, Axonal regeneration in PMGS-overexpressing cells can
be partially reversed by the PMGS inhibitor NeuAc2en. From the
experiments described in A and B, we
quantitated the number of cells from which a new axon grew from a
different neurite (gray bars) or from the same
process (black bars). Seventy percent of the control
cells grew a new axon from a different neurite; conversely, 71% of the
PMGS-overexpressing neurons (Overexp. PMGS) regrew from
the same process (means of three experiments). When overexpressing
neurons were treated with 0.5 mM NeuAc2en
(Overexp.PMGS+NeuAc2en), the effect was partially
reversed, and 60% of the cells grew a different neurite after axotomy
(mean of two experiments). Error bars correspond to SDs.
|
|
 |
DISCUSSION |
In this work we show that PMGS mRNA and protein levels are
significantly higher in hippocampal neurons at early stages of development than at late stages, both in situ and in culture
conditions. By virtue of the role of PMGS in the synthesis of plasma
membrane GM1 (Miyagi et al., 1999 ; Wada et al., 1999 ; Hasegawa et al., 2000 ), these first results support the notion that plasma membrane GM1
plays an important role in the early stages of neuronal
differentiation. In what concerns the well characterized hippocampal
neurons in primary culture, one of such differentiation roles seems to
be the regulation of axonal growth. In support of this, we here show that addition of the specific inhibitor of PMGS activity, NeuAc2en, reduced GM1 plasma membrane levels and arrested axonal growth. Similar
axonal growth retardation was observed blocking GM1 directly with
cholera toxin-subunit B. Consistently, overexpression of the murine
PMGS cDNA enhanced GM1 synthesis and facilitated axonal growth.
Additionally, we show that PMGS overexpression causes an early
polarization of cytoskeletal components such as MAP2 or tau. The
simplest explanation for such early polarization is the overall
acceleration of neuronal maturation triggered by high expression of
PMGS. However, without analysis of synaptic activity, such a conclusion
at this moment is a simple working hypothesis. Although our NeuAc2en
data do not permit us to exclude the involvement of GM1 in dendritic
growth, the PMGS overexpression experiment suggests that, at least at
these early stages, PMGS-GM1 is especially important for axon growth.
Indeed, we observed that all overexpressing neurons had long axons, but
the dendrites were no longer than those of non-overexpressing neurons.
Because our own overexpression experiments with tagged axonal
growth-unrelated membrane proteins (i.e., amyloid precursor
protein, synaptophysin) (Kaether et al., 2000 ) did not affect
axonal elongation, the results presented here point to the specific
"axonogenic" role of PMGS.
We also observed that PMGS is expressed at much higher levels in
neurons grown on laminin than in those grown on PLL and that the
inhibitory effect of NeuAc2en is more evident in neurons grown on
laminin than on those grown on PLL. Because the hippocampal region is rich in laminin (Nakagami et al., 2000 ) and hippocampal neurons express integrin receptors (Pinkstaff et al., 1999 ), the expression and functional data here reported raise the possibility that
PMGS may modulate axonal growth through an increase in the efficiency
of integrin-laminin interaction (McKerracher et al., 1996 ). Although
we present no experimental evidence in favor of this argument, except
for the correlation just reported, such modulation may be similar to
that between GM1 and the extracellular matrix protein galectin-1 in the
olfactory tract, an event essential for the enhancement of axonal
growth and proper directionality toward the olfactory bulb (Puche et
al., 1996 ; Kopitz et al., 1998 ).
The mechanisms by which the increase in surface PMGS levels and
activity modulate growth remain to be investigated. It is reasonable to
think that an axonal growth determinant acts on surface GM1 (see
introductory remarks), resulting in a signaling event that produces an
increase in PMGS synthesis and insertion in the axonal membrane. This
local increase in PMGS would then be followed by an increase in GM1
interaction with the ligand, thus stimulating changes in the dynamics
of membrane fusion-retrieval and actin and microtubule cytoskeleton
that are needed to support further growth. Consistent with the above
scenario are the following observations. (1) PMGS expression levels
increase in neuroblastoma cells exposed to differentiation agents
(Hasegawa et al., 2000 ) and in hippocampal neurons grown under
conditions in which axonal differentiation is favored (this work). (2)
Alteration of GM1 concentration in detergent-insoluble
glycosphingolipid-enriched domains (rafts) or its interaction with
antibodies (Ravichra and Joshi, 1999 ) affects the
phosphorylation state of some of the signaling proteins associated with
these domains, leading to changes in transmembrane signaling. (3)
Neuron-like cells treated with exogenous GM1 show enhanced
neuritogenesis accompanied by a disruption of the actin network and an
increased association of the MAP2 with actin filaments (Wang et al.,
1998 ). It is then conceivable that the localized increase in PMGS-GM1
leading to accelerated axonal elongation as shown here activates the
signaling events needed to trigger changes in the actin and microtubule
cytoskeleton required to support axonal formation and axonal elongation
(Andersen and Bi, 2000 ; Bradke and Dotti, 2000 ). This needs to be tested.
One last result worth discussing in some detail is the axonal regrowth
capability of PMGS-overexpressing neurons. It was shown previously that
sectioning the axon of a young hippocampal neuron in vitro
results in the formation of a new axon from a different neurite if the
axonal stump is as long as or shorter than any of the remaining
neurites (Goslin and Banker, 1991 ). We here show that this is indeed
the case for control neurons but not for neurons overexpressing PMGS.
These neurons consistently form the new axon from the lesioned axon,
regardless of the length of the stump (Fig.
6B,C). The role of PMGS in the
regeneration of axons was further supported when we demonstrated that
the inhibition of PMGS activity in overexpressing neurons reversed the
regenerating effect (Fig. 7C). One possibility is that the
abundant plasma membrane GM1 molecules have established interactions
with the extracellular matrix in a number that is more typical of
mature axons. This may have prematurely "matured" the
overexpressing neuron, which has now fixed axonal and dendritic fate.
Such a view is in agreement with our own data showing the premature
polarization of the cytoskeletal proteins tau and MAP2 in
PMGS-overexpressing neurons.
In addition to the cell biological significance, the lesioning
experiments may have a clinical ramification. Because overexpression of
PMGS facilitates the regrowth of the original axon and because PMGS
mRNA, protein, and enzyme activity levels are very low in the adult
hippocampus, one logical assumption is that regeneration of mature
neurons could be improved by increasing the activity of PMGS in
situ. Patients suffering from GM1 gangliosidosis present defects
in ganglioside lysosomal degradation (mutations on the acid
-galactosidase) with GM1 accumulation, leading to neurodegeneration. The proposed strategy of increasing PMGS activity should not pose such
a problem for neuronal systems with a normal lysosomal function, as was
the case with our hippocampal cultures. Despite that, testing the
effect of PMGS in vivo should rely on the use of inducible elements to allow for an accurate control of enzyme expression.
We are confident that the manipulation of PMGS expression in
vivo using novel gene delivery strategies will open new
possibilities in nervous system regeneration, an aspect of paramount
clinical significance.
 |
FOOTNOTES |
Received June 11, 2001; revised Aug. 6, 2001; accepted Aug. 24, 2001.
We thank Drs. Frank Bradke, Lola Ledesma, Jorge Santos Da Silva, and
Beatriz Gil for scientific advice and discussions, and Bianca Hellias
and Etienne Cassin for the preparation and maintenance of the
hippocampal neurons.
Correspondence should be addressed to Cavalieri Ottolenghi, Scientific
Institute, Universita degli Studi di Torino, A. O. San Luigi
Gonzaga, Regione Gonzole 10, 10043 Orbassano (TO), Italy. E-mail:
carlos.dotti{at}unito.it
 |
REFERENCES |
-
Andersen SSL,
Bi G
(2000)
Axon formation: a molecular model for the generation of neuronal polarity.
BioEssays
22:172-179[Web of Science][Medline].
-
Bradke F,
Dotti CG
(2000)
Establishment of neuronal polarity: lessons from cultured hippocampal neurons.
Curr Opin Neurobiol
10:574-581[Web of Science][Medline].
-
Caceres A,
Banker G,
Steward O,
Binder L,
Payne M
(1984)
MAP2 is localized to the dendrites of hippocampal neurons which develop in culture.
Brain Res
315:314-318[Medline].
-
Caceres A,
Banker GA,
Binder L
(1986)
Immunocytochemical localization of tubulin and microtubule-associated protein 2 during the development of hippocampal neurons in culture.
J Neurosci
6:714-722[Abstract].
-
Chaplin MF
(1986)
Monosaccharides.
In: Carbohydrate analysis. A practical approach (Chaplin MF,
Kennedy JF,
eds), pp 1-36. Oxford, UK: IRL.
-
Craig AM,
Banker G
(1994)
Neuronal polarity.
Annu Rev Neurosci
17:267-310[Web of Science][Medline].
-
de Hoop MJ,
Meyn L,
Dotti CG
(1998)
Culturing hippocampal neurons astrocytes from fetal rodent brain.
In: Cell biology: a laboratory handbook (Celis JE,
ed), pp 154-163. San Diego: Academic.
-
Dotti CG,
Sullivan CA,
Banker GA
(1988)
The establishment of polarity by hippocampal neurons in culture.
J Neurosci
8:1454-1468[Abstract].
-
Esch T,
Lemmon V,
Banker G
(1999)
Local presentation of substrate molecules directs axon specification by cultured hippocampal neurons.
J Neurosci
19:6417-6426[Abstract/Free Full Text].
-
Facci L,
Leon A,
Toffano G,
Sonnino S,
Ghidoni R,
Tettamanti G
(1984)
Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1.
J Neurochem
42:299-305[Web of Science][Medline].
-
Ferrari G,
Anderson BL,
Stephens RM,
Kaplan DR,
Greene LA
(1995)
Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors.
J Biol Chem
270:3074-3080[Abstract/Free Full Text].
-
Goslin K,
Banker G
(1991)
Rat hippocampal neurons in low-density culture.
In: Culturing nerve cells (Banker G,
Goslin K,
eds), pp 251-281. Cambridge, MA: MIT.
-
Harel R,
Futerman AH
(1993)
Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons.
J Biol Chem
268:14476-14481[Abstract/Free Full Text].
-
Hasegawa T,
Yamaguchi K,
Wada T,
Takeda A,
Itoyama Y,
Miyagi T
(2000)
Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation.
J Biol Chem
275:8007-8015[Abstract/Free Full Text].
-
Hata K,
Wada T,
Hasegawa A,
Kiso M,
Miyagi T
(1998)
Purification and characterization of a membrane-associated ganglioside sialidase from bovine brain.
J Biochem (Tokyo)
123:899-905[Abstract/Free Full Text].
-
Inokuchi J,
Mizutani A,
Jimbo M,
Usuki S,
Yamagishi K,
Mochizuki H,
Muramoto K,
Kobayashi K,
Kuroda Y,
Iwasaki K,
Ohgami Y,
Fujiwara M
(1997)
Up-regulation of ganglioside biosynthesis functional synapse formation memory retention by a synthetic ceramide analog (L-PDMP).
Biochem Biophys Res Commun
237:595-600[Web of Science][Medline].
-
Kaether C,
Skehel P,
Dotti CG
(2000)
Axonal membrane proteins are transported in distinct carriers: a two-color video microscopy study in cultured hippocampal neurons.
Mol Biol Cell
11:1213-1224[Abstract/Free Full Text].
-
Katoh-Semba R,
Skaper SD,
Varon S
(1984)
Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum and NGF-dependent effects on neuritic growth (and proliferation).
J Neurosci Res
12:299-310[Medline].
-
Kopitz J,
von Reitzenstein C,
Sinz K,
Cantz M
(1996)
Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells.
Gycobiology
6:367-376.
-
Kopitz J,
Muhl C,
Ehemann V,
Lehmann C,
Cantz M
(1997)
Effects of cell surface ganglioside sialidase inhibition on growth control differentiation of human neuroblastoma cells.
Eur J Cell Biol
73:1-9[Medline].
-
Kopitz J,
von Reitzenstein C,
Burchert M,
Cantz M,
Gabius HJ
(1998)
Galectin-1 is a mayor receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase on human neuroblastoma cells in culture.
J Biol Chem
273:11205-11211[Abstract/Free Full Text].
-
Kozac M
(1989)
The scanning model for translation: an update.
J Cell Biol
108:229-241[Abstract/Free Full Text].
-
Leeden RW
(1989)
Biosynthesis metabolism and biological effects of gangliosides.
In: Neurobiology of glycoconjugates (Margolis RU,
Margolis RK,
eds), pp 43-69. New York: Plenum.
-
Lein PJ,
Banker GA,
Higgins D
(1992)
Laminin selectively enhances axonal growth and accelerates the development of polarity by hippocampal neurons in culture.
Brain Res Dev Brain Res
69:191-197[Medline].
-
Manthorpe M,
Engvall E,
Ruoslahti E,
Longo GE,
Davis GE,
Varon S
(1983)
Laminin promotes neuritic regeneration from cultured peripheral and central neurons.
J Cell Biol
97:1882-1890[Abstract/Free Full Text].
-
Masco D,
Van de Walle M,
Spiegel S
(1991)
Interaction of ganglioside GM1 with the B subunit of cholera toxin modulates growth and differentiation of neuroblastoma N18 cells.
J Neurosci
11:2443-2452[Abstract].
-
McKerracher L,
Chamoux M,
Arregui CO
(1996)
Role of laminin and integrin interactions in growth cone guidance.
Mol Neurobiol
12:95-116[Web of Science][Medline].
-
Miyagi T,
Wada T,
Iwamatsu A,
Hata K,
Yoshikawa Y,
Tokuyama S,
Sawada M
(1999)
Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides.
J Biol Chem
274:5004-5011[Abstract/Free Full Text].
-
Mutoh T,
Tokuda A,
Guroff G,
Fujiki N
(1993)
The effect of the B subunit of cholera toxin on the action of nerve growth factor on PC12 cells.
J Neurochem
60:1540-1547[Web of Science][Medline].
-
Mutoh T,
Tokuda A,
Miyadai T,
Hamaguchi M,
Fujiki N
(1995)
Ganglioside GM1 binds to the Trk protein and regulates receptor function.
Proc Natl Acad Sci USA
92:5087-5091[Abstract/Free Full Text].
-
Nakagami Y,
Abe K,
Nishiyama N,
Matsuki N
(2000)
Laminin degradation by plasmin regulates long-term potentiation.
J Neurosci
20:2003-2010[Abstract/Free Full Text].
-
Panni MK,
Cooper JD,
Sofroniew MV
(1998)
Ganglioside GM1 potentiates NGF action on axotomised medial septal cholinergic neurons.
Brain Res
812:76-80[Web of Science][Medline].
-
Pinkstaff JK,
Detterich J,
Lynch G,
Gall C
(1999)
Integrin subunit gene expression is regionally differentiated in adult brain.
J Neurosci
19:1541-1556[Abstract/Free Full Text].
-
Pitto M,
Mutoh T,
Kuriyama M,
Ferraretto A,
Palestini P,
Masserini M
(1998)
Influence of endogenous GM1 ganglioside on TrkB activity in cultured neurons.
FEBS Lett
439:93-96[Web of Science][Medline].
-
Puche AC,
Poirier F,
Hair M,
Bartlett PF,
Key B
(1996)
Role of galectin-1 in the developing mouse olfactory system.
Dev Biol
179:274-287[Web of Science][Medline].
-
Quinn CC,
Gray GE,
Hockfield S
(1999)
A family of proteins implicated in axon guidance and outgrowth.
J Neurobiol
41:158-164[Web of Science][Medline].
-
Rabin SJ,
Mocchetti I
(1995)
GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA.
J Neurochem
65:347-354[Web of Science][Medline].
-
Ravichra B,
Joshi PG
(1999)
Regulation of transmembrane signaling by ganglioside GM1: interaction of anti-GM1 with neuro2A cells.
J Neurochem
73:557-567[Medline].
-
Reuter G,
Schauer R
(1994)
Determination of sialic acids.
Methods Enzymol
230:168-199[Web of Science][Medline].
-
Saito M,
Tanaka Y,
Tang CP,
Yu RK,
Ando S
(1995)
Characterization of sialidase activity in mouse synaptic plasma membranes its age-related changes.
J Neurosci Res
40:401-406[Web of Science][Medline].
-
Schnaar RL,
Needham LK
(1994)
Thin-layer chromatography of glycosphingolipids.
Methods Enzymol
230:371-389[Web of Science][Medline].
-
Schwartz M,
Spirman N
(1982)
Sprouting from chicken embryo dorsal root ganglion induced by nerve growth factor is specifically inhibited by affinity purified anti-ganglioside antibodies.
Proc Natl Acad Sci USA
79:6080-6083[Abstract/Free Full Text].
-
Schwarz A,
Rapaport E,
Hirschberg K,
Futerman AH
(1995)
A regulatory role for sphingolipids in neuronal growth, inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching.
J Biol Chem
270:10990-10998[Abstract/Free Full Text].
-
Skaper SD,
Katoh-Semba L,
Varon S
(1985)
GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions.
Brain Res
355:19-26[Medline].
-
Spoerri PE,
Rapport MM,
Mahadik SP,
Roisen FJ
(1988)
Inhibition of conditioned media mediated neuritogenesis of sensory ganglia by monoclonal antibodies to GM1 gangliosides.
Dev Brain Res
41:71-77.
-
Suter DM,
Forscher P
(1998)
An emerging link between cytoskeletal dynamics and cell adhesion molecules in growth cone guidance.
Curr Opin Neurobiol
8:106-116[Web of Science][Medline].
-
Tessier-Lavigne M,
Goodman CS
(1996)
The molecular biology of axon guidance.
Science
274:1123-1133[Abstract/Free Full Text].
-
Wada T,
Yoshikawa Y,
Tokuyama S,
Kuwabara M,
Akita H,
Miyagi T
(1999)
Cloning, expression and chromosomal mapping of a human ganglioside sialidase.
Biochem Biophys Res Commun
261:21-27[Web of Science][Medline].
-
Wang LJ,
Colella R,
Roisen FJ
(1998)
Ganglioside GM1 alters neuronal morphology by modulating the association of MAP2 with microtubules and actin filaments.
Brain Res Dev Brain Res
105:227-239[Medline].
-
Warren L
(1959)
The thiobarbituric assay of sialic acids.
J Biol Chem
234:1971-1978[Free Full Text].
-
Wu G,
Ledeen RW
(1991)
Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: putative role of GM1 ganglioside in differentiation.
J Neurochem
56:95-104[Web of Science][Medline].
-
Wu G,
Ledeen RW
(1994)
Gangliosides as modulators of neuronal Ca+.
Prog Brain Res
101:101-112[Medline].
Copyright © 2001 Society for Neuroscience 0270-6474/01/21218387-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Y Izumi, K Tokuda, K. O'Dell, C. Zorumski, and T Narahashi
Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants
Human and Experimental Toxicology,
December 1, 2008;
27(12):
911 - 917.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Miyagi, T. Wada, K. Yamaguchi, K. Hata, and K. Shiozaki
Plasma Membrane-associated Sialidase as a Crucial Regulator of Transmembrane Signalling
J. Biochem.,
September 1, 2008;
144(3):
279 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wu, Z.-H. Lu, A. G. Obukhov, M. C. Nowycky, and R. W. Ledeen
Induction of Calcium Influx through TRPC5 Channels by Cross-Linking of GM1 Ganglioside Associated with {alpha}5{beta}1 Integrin Initiates Neurite Outgrowth
J. Neurosci.,
July 11, 2007;
27(28):
7447 - 7458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Woronowicz, S. R. Amith, V. W Davis, P. Jayanth, K. De Vusser, W. Laroy, R. Contreras, S. O Meakin, and M. R Szewczuk
Trypanosome trans-sialidase mediates neuroprotection against oxidative stress, serum/glucose deprivation, and hypoxia-induced neurite retraction in Trk-expressing PC12 cells
Glycobiology,
July 1, 2007;
17(7):
725 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Woronowicz, S. R. Amith, K. De Vusser, W. Laroy, R. Contreras, S. Basta, and M. R. Szewczuk
Dependence of neurotrophic factor activation of Trk tyrosine kinase receptors on cellular sialidase
Glycobiology,
January 1, 2007;
17(1):
10 - 24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ueno, S. Saito, T. Wada, K. Yamaguchi, M. Satoh, Y. Arai, and T. Miyagi
Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility
J. Biol. Chem.,
March 24, 2006;
281(12):
7756 - 7764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Papini, L. Anastasia, C. Tringali, G. Croci, R. Bresciani, K. Yamaguchi, T. Miyagi, A. Preti, A. Prinetti, S. Prioni, et al.
The Plasma Membrane-associated Sialidase MmNEU3 Modifies the Ganglioside Pattern of Adjacent Cells Supporting Its Involvement in Cell-to-Cell Interactions
J. Biol. Chem.,
April 23, 2004;
279(17):
16989 - 16995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Crespo, A. R. Zurita, and J. L. Daniotti
Effect of Gangliosides on the Distribution of a Glycosylphosphatidylinositol-anchored Protein in Plasma Membrane from Chinese Hamster Ovary-K1 Cells
J. Biol. Chem.,
November 15, 2002;
277(47):
44731 - 44739.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|